The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: Experimental and pathophysiological considerations

Journal of Chemical Neuroanatomy

Volumn 20, Issue 3-4, 2000, Pages 215-224

  Gsell, Willy ^a   De Sadeleer, Christelle ^a   Marchalant, Yannick ^a   MacKenzie, Eric T ^a   Schumann, Pascale ^a   Dauphin, François ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

Acetylcholine; Activation; Alzheimer's disease; Cerebral metabolism; Coupling; Nitric oxide

Indexed keywords

ACETYLCHOLINE; NEUROTRANSMITTER; NITRIC OXIDE;

AEROBIC METABOLISM; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; GLYCOLYSIS; INFRARED SPECTROSCOPY; METABOLIC REGULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; ANIMALS; CEREBROVASCULAR CIRCULATION; HUMANS; MAGNETIC RESONANCE IMAGING; NEURONS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034468853     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(00)00095-8     Document Type: Article

References (92)

1. Effects of variations in interstimulus interval on activation-flow coupling response and somatosensory evoked potentials with forepaw stimulation in the rat
2. Coupling of neural activation to blood flow in the somatosensory cortex of rats is time-intensity separable, but not linear
3. L-NA-sensitive rCBF augmentation during vibrissal stimulation in type III nitric oxide synthase mutant mice
4. Autoradiographic mapping of cerebral blood flow responses to cholinergic stimulation of the rat substantia innominata: Modulatory effect of galanin
5. Neurochemical stimulation of the rat substantia innominata increases cerebral blood flow (but not glucose use) through the parallel activation of cholinergic and non-cholinergic pathways
6. Cerebrovascular evidence for a GABAergic modulation of the cholinergic vasodilatatory basalocortical system in the rat
7. The cholinergic hypothesis of geriatric memory dysfunction
8. Sustained effect of metrifonate on cerebral glucose metabolism after immunolesion of basal forebrain cholinergic neurons in rats
9. Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease
10. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells
11. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography
12. Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and position emission tomography
13. Cholinergic neurotransmission has different effects on cerebral glucose consumption and blood flow in young normals, aged normals, and Alzheimer's disease patients
14. Neuropathological stageing of Alzheimer-related changes
15. The cerebral metabolic consequences of nitric oxide synthase deficiency: Glucose utilization in endothelial and neuronal nitric oxide synthase null mice
16. A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation
17. Local uncoupling of the cerebrovascular and metabolic responses to somatosensory stimulation after neuronal nitric oxide synthase inhibition
18. Cholinergic function and intellectual decline in Alzheimer's disease
19. Characteristics of the in vitro vasoactivity of beta-amyloid peptides
20. Cholinergic and vasoactive intestinal polypeptidergic innervation of the cerebral arteries
21. Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment
22. Impaired brain microcirculation may trigger Alzheimer's disease
23. Critical threshold cerebral hypoperfusion causes Alzheimer's disease?
24. Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease
25. Muscarinic-but not nicotinic-acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: A possible role for the M5 receptor subtype
26. Local NADPH-diaphorase neurons innervate pial arteries and lie close or project to intracerebral blood vessels: A possible role for nitric oxide in the regulation of cerebral blood flow
27. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects
28. Regional cerebral oxygen supply and utilization in dementia
29. Altered cerebral energy metabolism in Alzheimer's disease: A PET study
30. Focal cortical blood flow activation is regulated by intrinsic cortical cholinergic neurons
31. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
32. Simultaneous analysis of the coupling between cerebral blood flow (CBF), cerebral glucose use (CGU) and neuronal activity in the rat during a somatosensory activation
33. Scopolamine reduces frontal cortex perfusion
34. Evaluation of the early response in fMRI in individual subjects using short stimulus duration
35. Dependence of oxygen delivery on blood flow in rat brain: A 7 tesla nuclear magnetic resonance study
36. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
37. NGF delays rather than prevents the cholinergic terminal damage and delayed neuronal death in the hippocampus after ischemia
38. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease
39. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease
40. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: Effects upon local cerebral blood flow and glucose use in the rat
41. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure and normal values
42. Characterization of CBF response to somatosensory stimulation: Model and influence of anesthetics
43. Nitric oxide synthase inhibition does not affect somatosensory evoked potentials in the rat
44. Nitric oxide: A modulator, but not a mediator, of neurovascular coupling in rat somatosensory cortex
45. Neurovascular relationships in hippocampal slices: Physiological and anatomical studies of mechanisms underlying flow-metabolism coupling in intraparenchymal microvessels
46. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy
47. Energy on demand
48. Modification of activity-dependent increases of cerebral blood flow by excitatory synaptic activity and spikes in rat cerebellar cortex
49. Glucose metabolism in cholinoceptive cortical rat brain regions after basal forebrain cholinergic lesion
50. Cerebral blood flow, glucose utilization, regional glucose, and ATP content during the maturation period of delayed ischemic injury in gerbil brain
51. Regional study of the co-localization of neuronal nitric oxide synthase with muscarinic receptors in the rat cerebral cortex
52. Genetic and molecular advances in Alzheimer's disease
53. Misery perfusion with preserved vascular reactivity in Alzheimer's disease
54. Frequency-dependent changes in cerebral blood flow and evoked potentials during somatosensory stimulation in the rat
55. Brain magnetic resonance imaging with contrast dependent on blood oxygenation
56. Scopolamine abolishes cerebral blood flow response to somatosensory stimulation in anesthetized cats: PET study
57. Altered energy metabolism in Alzheimer's disease
58. Beta-amyloid protein is widely distributed in the central nervous system of patients with Alzheimer's disease
59. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease
60. Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization
61. The cerebrovascular effects of physostigmine are not mediated through the substantia innominata
62. Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice
63. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET
64. Effect of propentofylline on hippocampal brain energy state and amyloid precursor protein concentration in a rat model of cerebral hypoperfusion
65. Loss of vessel wall viability in cerebral amyloid angiopathy
66. Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man
67. Does mental activity change the oxidative metabolism of the brain?
68. On the regulation of the blood-supply of the brain
69. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease
70. Vibratory stimulation increases and decreases the regional cerebral blood flow and oxidative metabolism: A positron emission tomography (PET) study
71. Hypoperfusion induces overexpression of beta-amyloid precursor protein mRNA in a focal ischemic rodent model
72. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity
73. Early temporal characteristics of cerebral blood flow and deoxyhemoglobin changes during somatosensory stimulation
74. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease
75. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system
76. Soluble Alzheimers beta-amyloid constricts the cerebral vasculature in vivo
77. Beta-amyloid-induced endothelial necrosis and inhibition of nitric oxide production
78. Cerebral ischemia affects glucose transporter kinetics across rat brain microvascular endothelium: Quantitative analysis by an in situ brain perfusion method
79. Preganglionic and postganglionic neurons responsible for cerebral vasodilation mediated by nitric oxide in anesthetized dogs
80. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer's type and vascular dementia with deep white matter changes
81. Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease
82. Interactions of cholinergic and glutamatergic neuronal systems in the functional activation of cerebral blood flow response: A PET study in unasthetized monkeys
83. Docasahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: A PET study in conscious monkeys
84. Functional activation of cerebral blood flow and metabolism before and after global ischemia of rat brain
85. Expression of glucose transporters in rat brain following transient focal ischemic injury
86. Model of blood-brain transfer of oxygen explains nonlinear flow-metabolism coupling during stimulation of visual cortex
87. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: Electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry
88. Autoradiographic evidence for flow-metabolism uncoupling during stimulation of the nucleus basalis of Meynert in the conscious rat
89. Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex
90. Excessive oxygen or glucose supply does not alter the blood flow response to somatosensory stimulation or spreading depression in rats
91. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein